Clinical trial Recruiting at 1 site Interventional Ages 1 Day to 1 Month

NAVA use in preterm neonates with respiratory distress syndrome

Official title: Neurally Adjusted Ventilatory Assist [NAVA] Versus Conventional Ventilation in Preterm Neonates With Respiratory Distress Syndrome

Run by Ain Shams University · NCT07926009 · Data updated 2026-11-12

This trial tests whether neurally adjusted ventilatory assist (NAVA) helps preterm babies with respiratory distress syndrome breathe more easily than conventional ventilation.

Quick facts

Study typeInterventional
Ages1 Day to 1 Month
SexAll
Enrollment30 (estimated)
SponsorAin Shams University
Academic / other
Locations1 site (Cairo, Abbasia)
StatusRecruiting
StartedJanuary 24, 2026
Main results expectedOctober 2027
Study endsJanuary 2028
Registry record updatedNovember 9, 2026
Trial IDNCT07926009 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Preterm neonates ≤34 weeks gestation with radiologically confirmed RDS who require invasive mechanical ventilation.

Probably not a fit

Neonates with respiratory distress from causes other than RDS, central or peripheral drive limitations, diaphragmatic anatomical defects, or certain cardiac conditions may not benefit from NAVA.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial compares neurally adjusted ventilatory assist (NAVA) to conventional SIMV ventilation in preterm neonates with respiratory distress syndrome who require invasive ventilation. NAVA uses the diaphragm's electrical activity to guide breaths, aiming to improve synchrony between patient effort and ventilator support. Improved synchrony can reduce work of breathing, lower peak airway pressures, and potentially enhance oxygenation while minimizing lung injury. Ventilation is delivered using Maquet Servo-n, Drager, or SLE ventilators, and eligible participants are ≤34 weeks gestation with RDS confirmed clinically and radiologically. The study will enroll neonates admitted to NICUs at Ain Shams University and follow standard safety monitoring and outcome assessments.

Why it matters

Potential benefit: If successful, NAVA could improve breathing efficiency and reduce lung injury risk in preterm infants requiring invasive ventilation.

How similar studies have gone: Previous evidence suggests improved synchrony and respiratory parameters with NAVA in preterm infants, supporting exploration in this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Gestational age ≤ 34 weeks.
2. Neonates that have RDS according to clinical and radiological findings
3. Neonates requiring invasive mechanical ventilation.

Exclusion Criteria:

* 1\) Preterm neonates that have respiratory distress due to causes other than respiratory distress syndrome including transient tachypnea of new born , congenital pneumonia and sepsis. 2)Central and peripheral conditions that limit the respiratory drive, as well as diaphragmatic anatomical defects in patients with an intact respiratory drive, comprise the contraindications to NAVA

  * Examples are the following:

    * Central disorder: paralytic drug use, respiratory drive suppression due to heavy sedation or brain injury.
    * Peripheral disorder: phrenic nerve injury, paralytic agent administration.
    * Structural (anatomical) disorder: esophageal atresia, diaphragmatic hernia. 3) Cardiac patients including aortic coarctation , double outlet right ventricle (DORV), Tetralogy of Fallot and Transposition of the great arteries (TGA). 4) Surgical patients including gastroschisis , omphalocele , tracheoesophageal fistula and congenital diaphragmatic hernia (CDH).

Where it's running

  • Neonatal Intensive Care Units (NICUs), Ain Shams University
    Cairo, Abbasia, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.